Tag: inari medical

inari

Inari Medical announces first enrolment in DEFIANCE trial evaluating clinical outcomes...

Inari Medical has announced that the first patient has been enrolled in DEFIANCE, a prospective randomised controlled trial (RCT) comparing the clinical outcomes of...
mechanical thrombectomy

Mechanical thrombectomy for DVT: Randomised data needed to boost growing evidence...

Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA)—the latest results...

New mechanical thrombectomy systems unlock possibilities for the treatment of venous...

 Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14...

New mechanical thrombectomy systems unlock possibilities for the treatment of venous...

This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies. Mechanical thrombectomy with the ClotTriever and FlowTriever systems (Inari Medical) opens...
flash

FLASH results demonstrate “excellent safety profile” of the FlowTriever system in...

Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 “real-world” patients. This is according to...

ClotTriever deemed a “game-changer” in deep vein thrombosis treatment

This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies. “I am finally very confident I have a device that...
ClotTriever

Inari Medical announces randomised controlled trial evaluating clinical outcomes of the...

Inari Medical has announced planned enrolment of the DEFIANCE randomised controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
February's

Interventional News’ top 10 most popular items of February 2022

The February top 10 features news of the recent Japanese randomised control trial results, which support the use of mechanical thrombectomy in ischaemic stroke...

AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...

Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system (Inari Medical) in a real-world deep vein...

First patient enrolled in PEERLESS study of FlowTriever system

Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomised controlled trial (RCT) comparing the outcomes of patients with...

Interventional News’ top 10 most popular items of January 2022

January’s top 10 features technological advancements, with Cook Medical receiving US Food and Drug Administration (FDA) approval for new drug-eluting stents and Adept Medical...
February's

Interventional News’ top 10 most popular items of January 2022

January’s top 10 features technological advancements, with Cook Medical receiving US Food and Drug Administration (FDA) approval for new drug-eluting stents and Adept Medical...

Six-month registry interim data flash early thrombectomy safety in pulmonary embolism...

Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism patients enrolled in the FlowTriever outcomes registry (FLASH). A...

Inari Medical announces six-month FLASH registry interim data

  Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism (PE) patients enrolled in the FlowTriever outcomes registry...

Inari Medical announces first patient enrolled in FLAME study

Inari Medical has announced the enrolment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....